Blood Monocyte Count Can Predict Early Response to Secukinumab Therapy in Patients With Psoriasis
Journal of Drugs in Dermatology · 2024
DOI: 10.36849/jdd.7525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, 2024. Verfasst von Dominika Ziolkowska-Banasik und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Psoriasis, Biological Products, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Ziolkowska-Banasik, D., Hadas, E., & Pastuszczak, M. (2024). Blood Monocyte Count Can Predict Early Response to Secukinumab Therapy in Patients With Psoriasis. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7525
Vancouver
Ziolkowska-Banasik D, Hadas E, Pastuszczak M. Blood Monocyte Count Can Predict Early Response to Secukinumab Therapy in Patients With Psoriasis. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.7525
BibTeX
@article{ZiolkowskaBanasik2024,
author = {Ziolkowska-Banasik, Dominika and Hadas, Ewa and Pastuszczak, Maciej},
title = {Blood Monocyte Count Can Predict Early Response to Secukinumab Therapy in Patients With Psoriasis},
journal = {Journal of Drugs in Dermatology},
year = {2024},
doi = {10.36849/jdd.7525}
}
EUVIMED